Company intelligence / Profile preview

Tahoe

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Tahoe (formerly Vevo Therapeutics) is in the preclinical stage, leveraging gigascale single-cell data and advanced AI models to discover novel drugs and targets in cancer; no clinical trial outcomes reported as of August 2025[1][2][5].

Therapeutic areas: Oncology
Modalities: Small moleculeBiologic(Platform supports broad range; specifics not fully disclosed)
Industry: Biotech

Partnerships

Arc InstituteNVIDIAUniversity of California, San Francisco (tech license) [2][4][5]

Beyond the preview

Go deeper on Tahoe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tahoe.

Explore the full profile